Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Aerosolized Albuterol in Mechanically Ventilated Infants With BPD
NCT02766673Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Aug 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of salbutamol in bronchopulmonary dysplasia (BPD) (3 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Change in Expiratory Flow Between Pre and Post-medication Dosing. Started Aug 2016; status: completed.
02
Drugs
salbutamol
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT02766673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02766673.